| appearance as argument number 1 |
|
| (documentation Lisdexamfetamine EnglishLanguage "Lisdexamfetamine, sold under the brand name Vyvanse among others, is a medication that is a derivative of Amphetamine. It is mainly used to treat attention deficit hyperactivity disorder (ADHD) in people over the age of five as well as moderate-to-severe binge eating disorder in adults. Lisdexamfetamine is taken by mouth. In the UnitedKingdom, it is usually less preferred than methylphenidate. Its effects generally begin within 2 hours and last for up to 14 hours. [from Wikipedia]") | Medicine.kif 3957-3964 | |
| (subclass Lisdexamfetamine Medicine) | Medicine.kif 3954-3954 | Lisdexamfetamine is a subclass of medicine |
| (subclass Lisdexamfetamine Stimulant) | Medicine.kif 3955-3955 | Lisdexamfetamine is a subclass of stimulant |
| appearance as argument number 2 |
|
|
| (diseaseMedicine AttentionDeficitHyperactivityDisorder Lisdexamfetamine Ingesting) | Medicine.kif 3967-3967 | AttentionDeficitHyperactivityDisorder is disease treatment lisdexamfetamine for ingesting |
| (subclass Vyvanse Lisdexamfetamine) | Medicine.kif 3969-3969 | Lisdexamfetamine is a subclass of lisdexamfetamine |
| (termFormat EnglishLanguage Lisdexamfetamine "lisdexamfetamine") | Medicine.kif 3966-3966 | Lisdexamfetamine is a subclass of lisdexamfetamine |
|
Show full definition with tree view
Show simplified definition (without tree view)
Show simplified definition (with tree view)
|
|
Sigma web home Suggested Upper Merged Ontology (SUMO) web home
Sigma version 3.0 is open source software produced by Articulate Software and its partners